Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Autoliv Research Advisory Board strengthens insights in human behavior

(Stockholm, Sweden, October 12, 2017) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, strengthens its insights in human behavior when Adrian Lund joins the Autoliv Research Advisory Board in 2018.Adrian Lund is President of the Insurance Institute for Highway Safety (IIHS) and its affiliate, the Highway Loss Data Institute (HLDI) in the United States. Dr. Lund’s research has spanned the range of driver, vehicle and roadway factors involved in the safety of motor vehicle travel. His publications include studies of young drivers and driver

Update and status of Karessa Pharma's project K-03

Karessa Pharma Holding AB is working actively to operate the most advanced project, K-03 Vardenafil buccal film, through its various development phases as effectively as possible.Status project K-03 Vardenafil buccal film Karessa submitted an application for a clinical trial with K-03 Vardenafil buccal film to the Medical Products Agency on 31stof August, which the market has previously been informed of. The company has received questions from the Medical Products Agency that has been answered and an approval is expected to arrive in late October. The project is proceeding according to

KONE publishes its Interim Report for January-September 2017 on Thursday, October 26, 2017 at 12:30 p.m. EEST

KONE Corporation, press release, October 12, 2017 at 9.30 a.m. EESTKONE publishes its Interim Report for January-September 2017 on Thursday, October 26, 2017 at 12:30 p.m. EEST Interim Report KONE Corporation will publish its Interim Report for the January 1-September 30, 2017 accounting period on Thursday, October 26, 2017 at 12:30 p.m. EEST. The report will be available on www.kone.com after publishing. Press and analyst meetings A meeting for the press, conducted in Finnish, will be held on Thursday, October 26, 2017 at 2:15 p.m. EEST. A meeting for analysts, conducted

DDM Debt finalizes its second Croatian acquisition

DDM Debt AB (Nasdaq Stockholm: DDM2) announces that it has finalized the previously announced acquisition of a distressed asset portfolio containing secured corporate receivables in Croatia from a leading international bank. DDM has received the approval from the Croatian National Bank, and has now finalized the acquisition, as set out in the press release dated 30 June 2017. The investment amounts to approximately EUR 21 million. The acquisition is financed by a combination of cash on hand and the recently announced revolving credit facility. This is information which DDM Debt AB

Clinical Study with BGB324, BerGenBio’s Selective First-in-Class AXL Inhibitor, to be Presented at the 9th World Congress of Melanoma

Bergen, Norway, Oct 12 2017 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors for multiple cancer indications, announces that the clinical trial of BGB324 in combination with either MEKINIST® (trametinib) plus TAFINLAR® (dabrafenib) or KEYTRUDA® in advanced melanoma, will be presented at the 9th World Congress of Melanoma in Brisbane, Australia, October 18-21, 2017.Dr. Oddbjørn Straume, consultant oncologist at Haukeland University Hospital and Professor at the University of Bergen Centre for Cancer Biomarkers will

Castellum’s Interim Report January–September 2017 to be published on October 20 – invitation to teleconference

On October 20, 2017, 08:00 am (CET), Castellum will present its Interim Report for January–September 2017. Investors, analysts and journalists are hereby invited to participate in a teleconference at 09:00 am (CET) on the same date.The teleconference will be hosted by Castellum’s CEO Henrik Saxborn and CFO Ulrika Danielsson. The presentation will be held in English. Date:                 October 20, 2017Time:                Report published 08:00 am (CET)                            Teleconference 09:00 am (CET) To participate in the teleconference, please dial in on any of the

MUNTERS RELEASES NEW VERSION OF PSYCHROAPP™ AND PROAPP DATACOM™

Munters HVAC calculators now available for Android Devices and iOSMunters announces its global launch of well-known PsychroApp (psychrometric calculator) and ProApp Datacom (used by data centers and critical facilities for sizing cooling systems and energy efficiency) for Android devices. Previously available for iOS platforms only, Munters is pleased to release Android versions, and also improved and updated iOS versions of both apps. Both iOS and Android PychroApp users will enjoy a fresh, clean look and feel with this latest release. Munters PsychroApp, the psychrometric calculation

Catella: European retail - investor`s favourite facing a transformation

The new Catella Market Tracker “European Retail Markets – Investors’ favourite facing a transformation” shows the increasing pressure on European retail formats from e-commerce. But countries such as the Nordics, France and the UK are evading this negative trend.Examining the transformation of shopping centres shows that traditional retail space is being continuously replaced with food service and event space, in new buildings and, particularly, in the refurbishments being made by value-add investors. The largest distortions can be found in the textile trade, which suggests that not all

MTG’s ‘Veni Vidi Vici’ to stream in US exclusively on Hulu

· MTG original series to premiere in US on Hulu in December 2017 · Second MTG original scripted drama acquired for world’s largest entertainment market Hulu has acquired the US streaming rights to MTG’s original series ‘Veni Vidi Vici’. The critically acclaimed series will make its US debut exclusively on the premium streaming service in December 2017. ‘Veni Vidi Vici’ originally premiered on MTG’s Nordic streaming service Viaplay in April this year and was part of the official selection at the 2017 MIPDrama Screenings 

DDM finalizes its second Croatian acquisition

DDM Holding AG (First North: DDM) announces that it has finalized the previously announced acquisition of a distressed asset portfolio containing secured corporate receivables in Croatia from a leading international bank. DDM has received the approval from the Croatian National Bank, and has now finalized the acquisition, as set out in the press release dated 30 June 2017. The investment amounts to approximately EUR 21 million. The acquisition is financed by a combination of cash on hand and the recently announced revolving credit facility. This is information which DDM Holding AG

InDex Pharmaceuticals gets new patent in the US

October 12, 2017 – InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod will be issued by the United States Patent and Trademark Office (USPTO). The patent provides additional protection for treating chronic active ulcerative colitis in patients that are not responding or are intolerant to anti-inflammatory therapy, wherein cobitolimod is not administered in combination with corticosteroid or glucocorticosteroid.The continuation patent, entitled Method for prevention of colectomy (patent number 9795627), will provide an

Tele2 AB: Third Quarter 2017 Result Presentation

The hosts of the presentation are Allison Kirkby, CEO, Lars Nordmark, CFO, and Erik Strandin Pers, Head of Investor Relations.Tele2 AB will announce its financial results for Q3 2017 at 07:00 am CEST (06:00 am BST/01:00 am EDT) on Thursday, October 19, 2017. Tele2 will host a presentation with the possibility to join through a conference call, for the global financial community at 10:15 am CEST (09:15 am BST/04:15 am EDT) on Thursday, October 19, 2017. The presentation will be held in English and also made available as a webcast on Tele2’s website: www.tele2.com. Dial-in information:

Invitation to the news conferences on Fortum's January-September 2017 Interim Report on 26 October 2017

FORTUM CORPORATION INVESTOR NEWS 12 OCTOBER 2017 AT 9.00 EESTFortum will publish its January-September 2017 Interim Report on Thursday 26October 2017 at approximately 9.00 EEST.Press conference for mediaA press conference in Finnish for media will be arranged at 11.00 EEST atFortum’s headquarters, Keilaniementie 1, Espoo, Finland. On arrival,participants are requested to show their press card and photo ID. A webcast ofthe conference can be followed live athttps://fortum.videosync.fi/2017-10-26-q3-osavuosikatsaus. Lunch will be servedat the event.Analyst and investor

Kamux Oyj: Publication schedule for Kamux Corporation's financial reporting in 2018

KAMUX CORPORATION   STOCK EXCHANGE RELEASE   12 October 2017 9:00   Publication schedule for Kamux Corporation's financial reporting in 2018   Kamux Corporation will publish its financial statements and interim reports in 2018 as follows: 8 March 2018: Financial Statements Bulletin 2017 24 May 2018: Kamux Corporation will publish its interim report for January-March 2018. 23 August 2018: Kamux Corporation will publish its half-yearly report for January-June 2018. 22 November 2018: Kamux Corporation will publish its interim report for January-September 2018.

OxThera appoints new Chief Medical Officer

Stockholm – 12 October 2017 – OxThera AB, a Stockholm-based privately-held biopharmaceutical company today announced the appointment of Dr Bastian Dehmel as their new Chief Medical Officer. OxThera is developing a novel treatment, Oxabact, for Primary hyperoxaluria (PH), a severe and often fatal disease in children, and where there are currently no available therapies. The company is poised to initiate a pivotal Phase III study in PH with Oxabact in order to stop and/or delay disease progression. “It is my pleasure to welcome Bastian as CMO of OxThera”, said Matthew Gantz, CEO of

KappAhl proposes a share split and automatic share redemption

The Board of Directors of KappAhl AB (publ) has decided to propose to the Annual General Meeting on 5 December 2017 to make a decision about a share split and reduction of the share capital through an automatic redemption procedure. Through the redemption procedure approximately SEK 500 million will be transferred to KappAhl's shareholders, corresponding to SEK 6.50 per share.The proposal means that each KappAhl share will be split into two shares, of which one will be a redemption share. The redemption shares will then automatically be redeemed against a cash redemption payment of SEK 6.50

Year-end report 1 September 2016 - 31 August 2017

Significant earinings improvement for the full year Operating income was SEK 4 M (6) in the fourth quarter. Sales for comparable stores in Sweden were stable and clearly above the negative market trend during the quarter. Year-on-year profit in the quarter was affected by a slightly lower gross margin, increased investments in marketing and delayed deliveries in Polarn O. Pyret. Full year operating income increased to SEK 63 M (36).FOURTH QUARTER, 1 JUNE 2017 – 31 AUGUST 2017, IN SUMMARY · Sales for comparable stores in Sweden decreased by 0.2 percent during the quarter, above the

KappAhl Year End Report 16/17: Improved performance

“The 2016/2017 financial year was yet another step towards KappAhl’s financial targets – to achieve an operating margin of 10 per cent and a sales increase of 4 per cent over a business cycle.”                                        Read the CEO statement on the Year End Report.· Sales in the quarter were unchanged, SEK 1,248 (1,248) million compared with the fourth quarter of the previous year and they increased by 4.1 per cent to SEK 4,916 (4,724) million during the year. · The gross margin increased by 2.7 percentage points to 60.7 (58.0) per cent during the quarter and by 0.4

Skanska rehabilitates George Washington Bridge in New York City, USA, for USD 452M, about SEK 3.9 billion

Skanska has signed a contract with the Port Authority of New York and Jersey to rehabilitate and replace supporting structures and provide upgrades for the George Washington Bridge in New York City, USA. The contract is worth USD 452M, about SEK 3.9 billion, which will be included in the US order bookings for the third quarter 2017.Skanska will replace suspender ropes and protective sleeves, rehabilitate the main cables, install dehumidification systems for the main cables and their anchorages, and replace the main span sidewalks and upper level railings with fencing. The project also

Viking Line’s successful environmental campaign donates 40,000 euros to the Baltic Sea: four environmental organizations are recipients

Viking Line has donated 40,000 euros to environmental efforts to protect the Baltic Sea. The donation, given to four different environmental organizations, comes from the sale of plastic carrier bags on board Viking Line’s vessels. The plastic bags are made from recycled plastic, with part of the material coming from our own on-board recycling. Among the activities to be funded by the donation are information campaigns, environmental work and the maintenance of recycling centres and lavatories in the Baltic Sea archipelagos.Viking Line’s successful environmental campaign with plastic bags

RNB acquires the e-commerce player Frontmen.com

The retail group RNB is increasing its focus on the digital development and acquires Frontmen.com.RNB launched Man of a kind one year ago, an e-commerce destination with focus on exclusive men’s fashion. This as part of the group’s strategy to develop the digital sales channels. Frontmen.com, an established online player within men’s fashion, is now being acquired. Frontmen was founded in 2008 by the fashion profile Oscar Arrsjö whom together with Mats Ljungström, Erik Paulsson’s company Backahill, and the private equity firm Wellstreet owns this business through the company Fashionisland

Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer

Oslo, Norway, 11 October 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces one-year data on survival rate, immune activation and safety in the modified cohort of the TG01 trial in resected pancreatic cancer patients. The trial is an open label, phase I/II trial of TG01/GM-CSF in combination with gemcitabine as adjuvant therapy for treating patients with resected adenocarcinoma of the pancreas. The trial consists of two cohorts: the main cohort of 19 patients and a

Multiconsult ASA – Repurchase of own shares

On 11 October 2017, Multiconsult ASA ("Multiconsult") purchased 8 500 of its own shares at an average price of NOK 86.10 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 62 545 of its own shares.       For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

There are no items matching the current filter
There are no more items matching the current filter
Back to top